Ver registro no DEDALUS
Exportar registro bibliográfico

Metrics


Metrics:

Use of direct oral anticoagulants for chronic throm-boembolic pulmonary hypertension (2018)

  • Authors:
  • USP affiliated authors: TERRA FILHO, MARIO - FM ; SOUZA, ROGÉRIO DE - FM
  • USP Schools: FM; FM
  • DOI: 10.6061/clinics/2018/e216
  • Subjects: TROMBOEMBOLISMO; HIPERTENSÃO PULMONAR; ANTICOAGULANTES; DOENÇA CRÔNICA
  • Language: Inglês
  • Imprenta:
  • Source:
    • Título do periódico: Clinics
    • ISSN: 1807-5932
    • Volume/Número/Paginação/Ano: v. 73, article ID UNSP e216, 2p, 2018
  • Acesso online ao documento

    Online accessDOI or search this record in
    Informações sobre o DOI: 10.6061/clinics/2018/e216 (Fonte: oaDOI API)
    • Este periódico é de acesso aberto
    • Este artigo é de acesso aberto
    • URL de acesso aberto
    • Cor do Acesso Aberto: gold
    • Licença: cc-by
    Versões disponíveis em Acesso Aberto do: 10.6061/clinics/2018/e216 (Fonte: Unpaywall API)

    Título do periódico: Clinics

    ISSN: 1807-5932,1980-5322

    • Melhor URL em Acesso Aberto:


    • Outras alternativas de URLs em Acesso Aberto:


        • Página do artigo
        • Evidência: oa journal (via doaj)
        • Licença: cc-by
        • Versão: publishedVersion
        • Tipo de hospedagem: publisher


        • Página do artigo
        • Link para o PDF
        • Evidência: oa repository (via OAI-PMH title and first author match)
        • Licença: cc-by
        • Versão: publishedVersion
        • Tipo de hospedagem: repository



    How to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      GAVILANES-OLEAS, Francisca Alexandra; TERRA-FILHO, Mario; SOUZA, Rogerio. Use of direct oral anticoagulants for chronic throm-boembolic pulmonary hypertension. Clinics, Sao Paulo, v. 73, 2018. Disponível em: < http://dx.doi.org/10.6061/clinics/2018/e216 > DOI: 10.6061/clinics/2018/e216.
    • APA

      Gavilanes-oleas, F. A., Terra-filho, M., & Souza, R. (2018). Use of direct oral anticoagulants for chronic throm-boembolic pulmonary hypertension. Clinics, 73. doi:10.6061/clinics/2018/e216
    • NLM

      Gavilanes-oleas FA, Terra-filho M, Souza R. Use of direct oral anticoagulants for chronic throm-boembolic pulmonary hypertension [Internet]. Clinics. 2018 ; 73Available from: http://dx.doi.org/10.6061/clinics/2018/e216
    • Vancouver

      Gavilanes-oleas FA, Terra-filho M, Souza R. Use of direct oral anticoagulants for chronic throm-boembolic pulmonary hypertension [Internet]. Clinics. 2018 ; 73Available from: http://dx.doi.org/10.6061/clinics/2018/e216

    Referências citadas na obra
    1. ISTH Steering Committee for World Thrombosis Day. Thrombosis: a major contributor to global disease burden. Thromb Res. 2014;134((5)):931–8. http://dx.doi.org/10.1016/j.thromres.2014.08.014 [PubMed]
    2. Kernohan RJ, Todd C. Heparin therapy in thromboembolic disease. Lancet. 1966;1((7438)):621–3. http://dx.doi.org/10.1016/S0140-6736(66)90822-1 [PubMed]
    3. Barritt DW, Jordan SC. Anticoagulant drugs in the treatment of pulmonary embolism. A controlled trial. Lancet. 1960;1((7138)):1309–12. http://dx.doi.org/10.1016/S0140-6736(60)92299-6 [PubMed]
    4. Hull R, Delmore T, Genton E, Hirsh J, Gent M, Sackett D, et al. Warfarin sodium versus low-dose heparin in the long-term treatment of venous thrombosis. N Engl J Med. 1979;301((16)):855–8. http://dx.doi.org/10.1056/NEJM197910183011602 [PubMed]
    5. Fernandes CJ, Alves Júnior JL, Gavilanes F, Prada LF, Morinaga LK, Souza R. New anticoagulants for the treatment of venous thromboembolism. J Bras Pneumol. 2016;42((2)):146–54. http://dx.doi.org/10.1590/S1806-37562016042020068 [PMC free article] [PubMed]
    6. Kearon C, Akl EA, Ornelas J, Blaivas A, Jimenez D, Bounameaux H, et al. Antithrombotic Therapy for VTE Disease: Chest Guideline and Expert Panel Report. Chest. 2016;149((2)):315–52. http://dx.doi.org/10.1016/j.chest.2015.11.026 [PubMed]
    7. Kim NH. Group 4 Pulmonary Hypertension: Chronic Thromboembolic Pulmonary Hypertension: Epidemiology, Pathophysiology, and Treatment. Cardiol Clin. 2016;34((3)):435–41. http://dx.doi.org/10.1016/j.ccl.2016.04.011 [PubMed]
    8. Costa EL, Jardim C, Bogossian HB, Amato MB, Carvalho CR, Souza R. Acute vasodilator test in pulmonary arterial hypertension: evaluation of two response criteria. Vascul Pharmacol. 2005 Sep;43((3)):143–7. http://dx.doi.org/10.1016/j.vph.2005.05.004 [PubMed]
    9. Hoeper MM, Humbert M, Souza R, Idrees M, Kawut SM, Sliwa-Hahnle K, et al. A global view of pulmonary hypertension. Lancet Respir Med. 2016 Apr;4((4)):306–22. http://dx.doi.org/10.1016/S2213-2600(15)00543-3 [PubMed]
    10. Galiè N, Humbert M, Vachiery JL, Gibbs S, Lang I, Torbicki A, et al. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS)Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT) Eur Heart J. 2016;37((1)):67–119. http://dx.doi.org/10.1093/eurheartj/ehv317 [PubMed]
    11. Kim NH, Simonneau G. Future Directions in Chronic Thromboembolic Pulmonary Hypertension. Disease at a Crossroads? Ann Am Thorac Soc. 2016;13((Suppl 3)):S255–8. http://dx.doi.org/10.1513/AnnalsATS.201601-065AS [PubMed]
    12. Gouin B, Robert-Ebadi H, Righini M, Blondon M. Pharmacological management of pulmonary embolism. Expert Opin Pharmacother. 2017;18((1)):79–93. http://dx.doi.org/10.1080/14656566.2016.1268122 [PubMed]